Enanta Pharma (ENTA) Misses Q3 EPS by 6c
Enanta Pharma (NASDAQ: ENTA) reported Q3 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
Enanta Pharma (NASDAQ: ENTA) reported Q3 EPS of $0.13, $0.06 worse than the analyst estimate of $0.19.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.